Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Sector Perform Rating on GoodRx Holdings with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Insuring Better Health: How Insurance Acceptance is Changing Diabetes Care
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Sean Dodge, an analyst at RBC Capital, has reiterated his Sector Perform rating on GoodRx Holdings (NASDAQ: GDRX) and increased the price target to $8, up from $7. This adjustment is in line with the predictions of other analysts, who have an average price target of $7.39 for the stock. The high estimate is $14, while the low estimate is $4.50. The consensus rating for GoodRx Holdings is a Moderate Buy, with 4 buy ratings, 6 hold ratings, and 1 sell rating. Analysts believe the stock has an upside potential of approximately 13.34% based on their average price targets.

Date: March 1, 2024

GoodRx Holdings Inc. (GDRX) Shows Strong Performance in Stock Market on March 1, 2024

On March 1, 2024, GoodRx Holdings Inc. (GDRX) showed strong performance in the stock market. According to data from CNN Money, GDRX was trading near the top of its 52-week range and above its 200-day simple moving average, indicating positive price momentum for the stock.

Throughout the trading day, GDRX saw a significant increase in its share price. The stock opened at $8.32, which was $0.53 higher than its previous close. By the end of the day, the price of GDRX shares had increased by $0.62, representing a 7.96% rise from the market’s last close.

This price movement reflects investor optimism and confidence in GDRX’s performance and future prospects. The strong price momentum and positive price change on March 1 suggest that the stock may be attracting interest from investors and traders.

Investors should conduct thorough research and analysis before making any investment decisions. Overall, the performance of GDRX on March 1, 2024, indicates that the stock had a strong trading day with significant price gains, signaling a bullish outlook for GDRX in the near term. Investors and analysts will likely continue to monitor the stock’s performance and watch for any further developments that may impact its price.

GDRX Stock Performance Analysis: Revenue Flat, Net Loss Improves, EPS Shows Positive Growth

On March 1, 2024, GDRX stock showed mixed performances based on the financial data provided by CNN Money. The total revenue for the company was reported at $750.26 million for the past year, which remained flat compared to the previous year. However, there was a 9.27% increase in total revenue since the last quarter, with the figure standing at $196.64 million.

In terms of net income, GDRX reported a net loss of $8.87 million for the past year, which represented a significant improvement of 72.99% compared to the previous year. However, the net income for the last quarter was reported at a loss of $25.87 million, showing no change from the previous quarter.

Earnings per share (EPS) for GDRX also showed positive growth, with a reported EPS of -$0.02 for the past year, reflecting a 72.83% increase compared to the previous year. The EPS for the last quarter was reported at -$0.06, showing no change from the previous quarter.

Tags: GDRX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Mining technology

Collective Audience Acquires BeOp Enhancing AdTech Platform with AI and Conversational Advertising

Analyst Upgrades Cardiff Oncology Stock with Higher Price Target

Bitcoin crypto on laptop

Analyst Bullish on Elastic NYSE ESTC with Increased Price Target

Recommended

Amazon_charge

Positive Outlook for Novo Nordisks Obesity Drug Wegovy and the Future of Obesity Drugs

2 years ago
Food Retailers Stock Market Today

DA Davidson Analyst Reaffirms Buy Rating on Campbell Soup with Lowered Price Target

2 years ago

Everest Re Group Sees Reduction in Stake by Allspring Global Investments Holdings LLC Amidst Strong Financial Performance

2 years ago
Regenxbio Stock

Regenxbio Shares Slide as FDA Pushes Back Key Drug Decision

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

Gladstone Capital Executes Strategic Debt Refinancing and Rewards Shareholders

Executive Share Sales and Management Shifts Raise Questions at Repay Holdings

EU Data Act Fuels Momentum for Cybersecurity ETF

Dentsply Sirona’s Rocky Road to Recovery

Trending

BioNTech Stock
Earnings

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

by Andreas Sommer
September 22, 2025
0

The German biotechnology firm BioNTech is navigating a critical strategic transition. Having achieved global recognition through its...

Nestle Stock

Leadership Crisis at Nestlé Sparks Investor Concerns

September 22, 2025
Standex Stock

Standex Shares Plunge Amid Technical Warnings and Insider Selling

September 22, 2025
Synchrony Stock

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

September 22, 2025
Vanguard Information Technology Index Fund ETF Shares Stock

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation
  • Leadership Crisis at Nestlé Sparks Investor Concerns
  • Standex Shares Plunge Amid Technical Warnings and Insider Selling

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com